Cyst Fluid Carcinoembryonic Antigen Level Difference between Mucinous Cystic Neoplasms and Intraductal Papillary Mucinous Neoplasms.

Creative Commons License

Köker I. H., Ünver N., Malya F. Ü., Uysal Ö., Keskin E., Şentürk H.

Clinical endoscopy, vol.54, pp.113-121, 2021 (ESCI, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 54
  • Publication Date: 2021
  • Doi Number: 10.5946/ce.2020.083
  • Journal Name: Clinical endoscopy
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, EMBASE, Directory of Open Access Journals
  • Page Numbers: pp.113-121
  • Keywords: Carcinoembryonic antigen, Malignancy, Pancreatic cysts, INTERNATIONAL CONSENSUS GUIDELINES, PANCREATIC CYSTS, DIAGNOSIS, MANAGEMENT, CEA, CLASSIFICATION, COMBINATION, PERFORMANCE, ACCURACY, FEATURES
  • Open Archive Collection: AVESIS Open Access Collection
  • Bezmialem Vakıf University Affiliated: Yes

Abstract

Background/Aims: The role of cyst fluid carcinoembryonic antigen (CEA) level in differentiating mucinous pancreatic cystic lesions (PCLs) is controversial. We investigated the role of cyst fluid CEA in differentiating low-risk (LR)-intraductal papillary mucinous neoplasms (IPMNs) from high-risk (HR)-IPMNs and LR-mucinous cystic neoplasms (MCNs).